Laura Adams is an associate in the Health Sciences Department of Pepper Hamilton LLP, resident in the Philadelphia office. Ms. Adams focuses her practice on the defense of pharmaceutical and medical device manufacturers in litigation, including federal multidistrict litigation and state coordinated proceedings. She has experience in all phases of pretrial preparation, including drafting pleadings, dispositive motions, and motions in limine; taking depositions and preparing both fact and expert witnesses to be deposed; and drafting written discovery and responses.
In addition, Ms. Adams has experience representing pharmaceutical companies in government investigations and qui tam litigation involving the Anti-Kickback Statute, False Claims Act, and parallel state statutes. She has counseled clients and drafted policies regarding compliance with state and federal regulations.
Ms. Adams also brings to her practice a keen interest in electronic discovery. In 2013, Ms. Adams was one of only fifteen authors in the nation to receive a Burton Award for Distinguished Legal Writing for her article “Reconsidering Spoliation Doctrine through the Lens of Tort Law,” 84 TEMP. L. REV. 137 (2012), which discusses spoliation sanctions in the federal courts. Her presentations include “Plaintiffs’ Expanding Playbook” (co-author), DRI Drug & Device Seminar (May 16, 2014).
Ms. Adams is an active member of the Philadelphia legal community. Most recently, in March 2014, she participated in the inaugural workshop event for Philly Law Lab, an organization dedicated to fostering innovation within the legal services community.
Ms. Adams has served as a member and co-chair of the firm’s Summer Associate Committee.
Ms. Adams began her career at Pepper as a paralegal, and rejoined the firm as an associate after a clerkship with the Honorable Rosemary E. Ramsay in New Jersey Superior Court.